{"id":256364,"date":"2014-09-25T18:48:25","date_gmt":"2014-09-25T22:48:25","guid":{"rendered":"http:\/\/www.eugenesis.com\/nanoparticle-synthesis-benefits-from-award-winning-syrris-batch-and-flow-reactors\/"},"modified":"2014-09-25T18:48:25","modified_gmt":"2014-09-25T22:48:25","slug":"nanoparticle-synthesis-benefits-from-award-winning-syrris-batch-and-flow-reactors","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/nanoparticle-synthesis-benefits-from-award-winning-syrris-batch-and-flow-reactors.php","title":{"rendered":"Nanoparticle Synthesis Benefits From Award-winning Syrris Batch and Flow Reactors"},"content":{"rendered":"<p><p>          Innovative batch and flow reactors          from leading manufacturer Syrris are proving advantageous          for a variety of nanoparticle applications, offering          scientists working in the field numerous benefits. Simple          to assemble with no tools required, the easy-to-use          reactors enable conditions such as temperature, time,          mixing, reagent ratios and concentrations to be quickly          varied for rapid process optimization. Excellent mixing          and temperature control ensure a narrow particle size          distribution and, to further enhance reproducibility, the          systems can be fully automated.        <\/p>\n<p>          Batch reactors such as the modular Atlas system offer          multiple sensors including temperature, pH and turbidity,          and have no particle size restrictions. With a large          choice of reactor sizes, process scale-up is          straightforward. One company successfully performing          batch synthesis of nanoparticles is Spanish nanomedicine          company Midatech Biogune. \"Our Atlas Potassium reactors          have allowed us to scale-up production, enabling          variables such as pH and temperature to be tightly          controlled,\" said CEO Justin Barry. Flow chemists have          enjoyed similar success, with Paulina Lloret, a          researcher at the Argentinian National Institute of          Industrial Technologies, saying, \"We trialed our          nanoparticle experiments on the Asia flow chemistry          system, and immediately placed an order for our own          system to optimize the speed and results of our synthesis          workflow\". The flexible Asia system's fast and          reproducible mixing, excellent heat transfer and accurate          temperature control, plus a wide range of flow rates,          allow process optimization and production on the same          reactor. This high level of control has enabled synthesis          of nanoparticles not previously seen using batch          techniques.        <\/p>\n<p>          Syrris Limited          Syrris is world renowned for excellence in chemical          reactor systems and is a world leader in flow chemistry          systems. Established in 2001, Syrris employs over 30          scientists and engineers at its facility in Royston (near          Cambridge, UK) and has offices in the US, Japan, India          and Brazil plus over 30 distributors worldwide.        <\/p>\n<p>          Syrris develops laboratory automation products for          research and development chemists in industries such as          pharma, petrochem, agrochem, fine chemical synthesis etc.          as well as academia. Syrris products are used in a wide          variety of applications and laboratories including          process, discovery, crystallization, process safety,          scale-up and many more.        <\/p>\n<p>          Syrris products include the innovative range of fully          automated batch reactor products (Atlas), a manually          operated jacketed reactor platform (Globe) and flow          chemistry systems (Asia and Africa). In recognition of          its technological achievements, Syrris has been awarded          the \"Eastern Region's UKTI Best Established Exporter\" and          the \"Most Outstanding Export Achievement\" at the Global          Opportunity Conference on International Trade. Syrris'          Asia Flow Chemistry system was the recipient of a          prestigious 2012 RD award.        <\/p>\n<p>           2014 kdm communications limited        <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" href=\"http:\/\/news.thomasnet.com\/companystory\/Nanoparticle-Synthesis-Benefits-From-Award-winning-Syrris-Batch-and-Flow-Reactors-20033331\/RK=0\/RS=adLFZTqujZAFRjvpV.vGXBmxdmw-\" title=\"Nanoparticle Synthesis Benefits From Award-winning Syrris Batch and Flow Reactors\">Nanoparticle Synthesis Benefits From Award-winning Syrris Batch and Flow Reactors<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Innovative batch and flow reactors from leading manufacturer Syrris are proving advantageous for a variety of nanoparticle applications, offering scientists working in the field numerous benefits. Simple to assemble with no tools required, the easy-to-use reactors enable conditions such as temperature, time, mixing, reagent ratios and concentrations to be quickly varied for rapid process optimization. Excellent mixing and temperature control ensure a narrow particle size distribution and, to further enhance reproducibility, the systems can be fully automated <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/nanoparticle-synthesis-benefits-from-award-winning-syrris-batch-and-flow-reactors.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577779],"tags":[],"class_list":["post-256364","post","type-post","status-publish","format-standard","hentry","category-nanomedicine-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256364"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=256364"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256364\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=256364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=256364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=256364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}